Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea
· Delayed Price · Currency is KRW
11,260
-750 (-6.24%)
At close: Mar 9, 2026
KOSDAQ:014950 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 |
| Debt / EBITDA Ratio | 0.03 | 0.02 | 0.05 |
| Debt / FCF Ratio | 0.08 | 0.03 | 0.23 |
| Net Debt / Equity Ratio | -0.36 | -0.25 | -0.18 |
| Net Debt / EBITDA Ratio | -3.79 | -2.55 | -2.10 |
| Net Debt / FCF Ratio | -9.43 | -3.62 | -9.80 |
| Asset Turnover | - | 0.91 | - |
| Inventory Turnover | - | 1.56 | - |
| Quick Ratio | 2.21 | 2.09 | 2.03 |
| Current Ratio | 3.40 | 3.27 | 3.23 |
| Return on Equity (ROE) | - | 7.02% | - |
| Return on Assets (ROA) | - | 3.73% | - |
| Return on Invested Capital (ROIC) | 8.08% | 7.55% | 6.10% |
| Return on Capital Employed (ROCE) | 6.50% | 6.80% | 5.60% |
| Payout Ratio | 7.65% | 7.98% | 4.73% |
| Buyback Yield / Dilution | -1.61% | -0.15% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.